Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 12:11 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 457–480 of 16,403 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Central Nervous System Disorder Clear all

Conditions: Descending Aortic Dissection, Postoperative Pain, Thoracoabdominal Aortic Aneurysm
Interventions: Saline, Ketamine; Drug
Lead sponsor: Eric Johnson; Other
Eligibility: 18 Years to 90 Years
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Parkinson Disease
Interventions: Immediate treatment, Deferred treatment; Behavioral
Lead sponsor: Teachers College, Columbia University; Other
Eligibility: 50 Years to 80 Years
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Multiple Sclerosis, Traumatic Brain Injury
Interventions: Emotional Processing Training, Placebo Control; Behavioral
Lead sponsor: Kessler Foundation; Other
Eligibility: 18 Years to 65 Years
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: East Hanover, New Jersey

Conditions: Dementia With Lewy Bodies
Interventions: Terazosin Hydrochloride, Placebo; Drug · Other
Lead sponsor: Qiang Zhang; Other
Eligibility: 0 Years to 90 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2030
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Glioblastoma Multiforme, Anaplastic Astrocytoma, Malignant Brain Tumor, High Grade Glioma
Interventions: Cabozantinib; Drug
Lead sponsor: Indiana University; Other
Eligibility: 2 Years to 21 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Stroke, Aphasia
Interventions: HD-tACS, Sham HD-tACS; Device
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2033
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Parkinson Disease, Mild Cognitive Impairment
Interventions: Strategy Training (Time- and Event- Based); Behavioral
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 50 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Brain Cancer, CNS Cancer
Interventions: FACBC, Methionine, PET Scan; Drug · Other
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: Not listed
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2019
U.S. locations: 1
States / cities: New York, New York

Conditions: Severe Alzheimer Disease
Interventions: GRF6019, Placebo; Drug · Other
Lead sponsor: Alkahest, Inc.; Industry
Eligibility: 60 Years to 95 Years
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 6
States / cities: Gilbert, Arizona • Mesa, Arizona • Phoenix, Arizona + 3 more

Conditions: Alzheimer Disease
Interventions: SPECT scan; Drug
Lead sponsor: Institute for Neurodegenerative Disorders; Other
Eligibility: 50 Years and older
Enrollment: 1 participant
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 2
States / cities: New Haven, Connecticut

Conditions: Vasculitis, CNS, Vasculitis, Cerebral
Interventions: MRI, including intracranial vessel wall imaging; Diagnostic Test
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Dementia
Interventions: I-HTC; Behavioral
Lead sponsor: New York University; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Phelan-McDermid Syndrome, Epilepsy
Interventions: AMO-01; Drug
Lead sponsor: Alexander Kolevzon; Other
Eligibility: 12 Years to 45 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 2
States / cities: New York, New York • Houston, Texas

Conditions: Cerebral Palsy
Interventions: APPLES-tele, Parent-centered Approach (PCA) Support Intervention, Standard of Care; Other · Behavioral
Lead sponsor: Emory University; Other
Eligibility: 4 Months to 13 Months
Enrollment: 269 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 4
States / cities: Atlanta, Georgia • Baltimore, Maryland • Philadelphia, Pennsylvania + 1 more

Conditions: Central Nervous System Tumors, Brain Tumor
Interventions: temozolomide; Drug
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2016
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Migraine Disorders
Interventions: Serotona Plus and dietary behavior management; Behavioral
Lead sponsor: Dynamic Health Resources; Industry
Eligibility: 18 Years to 72 Years
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Chesapeake, Virginia

Conditions: Aging, Cognitive Ability, General
Interventions: Moderate-aerobic walking, Positron Emission Tomography (PET) scan, Healthy living education, Physical activity monitor; Behavioral · Radiation · Device
Lead sponsor: University of Southern California; Other
Eligibility: 55 Years to 80 Years
Enrollment: 66 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2022
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Epilepsy
Interventions: Brivaracetam; Drug
Lead sponsor: UCB Pharma; Industry
Eligibility: 16 Years to 75 Years
Enrollment: 88 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 26
States / cities: Phoenix, Arizona • Fresno, California • Pasadena, California + 23 more

Conditions: Carotid Artery Stenosis, Strokes
Interventions: Statin, Atorvastatin, Placebo; Drug · Other
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 7
States / cities: Ridgewood, New Jersey • Albany, New York • Buffalo, New York + 1 more

Conditions: Sleep Apnea, Obstructive, Stroke, Patient Adherence
Interventions: Continuous Positive Airway Pressure; Device
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Cerebral Palsy
Interventions: Standardized Constraint-Induced Movement Therapy, Vibration, Placebo (for vibration); Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 3 Years to 9 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Apathy, Stroke, Stroke Sequelae, Stroke/Brain Attack, Stroke/ Cerebrovascular Accident (Ischemic or Hemorrhagic), Motivation, Abulia
Interventions: MagVenture MagPro Transcranial Magnetic Stimulation (TMS) System (Active), MagVenture MagPro Transcranial Magnetic Stimulation (TMS) System (Sham), Brainsight Neuronavigation System; Device · Other
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 40 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Friedreich Ataxia, Healthy Volunteers
Interventions: Buccal Swabs, Blood Draws and Skin Punch Biopsy; Diagnostic Test
Lead sponsor: Larimar Therapeutics, Inc.; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Eatontown, New Jersey

Conditions: Spinal Cord Injuries
Interventions: Cultured Allogeneic Adult Umbilical-cord or Placental Derived Mesenchymal Stem Cell Intrathecal injection; Biological
Lead sponsor: The Foundation for Orthopaedics and Regenerative Medicine; Other
Eligibility: Not listed
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Naples, Florida

Search by objective public record fields.

Ketamine in Patients Undergoing TEVAR Procedures Receiving NCI

Noise-augmented Automatic Speech Recognition for Speech Treatment in Parkinson's Disease

Remediation of Emotional Deficits in Multiple Sclerosis and Traumatic Brain Injury

Terazosin for Dementia With Lewy Bodies

Pilot Study of Cabozantinib for Recurrent or Progressive Central Nervous System Tumors in Children

Transcranial Alternating Current Stimulation (tACS) for the Recovery of Phonological Short-Term Memory in Patients With Aphasia After Stroke

Everyday Memory Impairment in PD-related Cognitive Decline

Imaging Brain Tumors With FACBC and Methionine

A Study to Assess the Safety of GRF6019 Infusions in Subjects With Severe Alzheimer's Disease

Evaluation of [123I] AV151 and SPECT in Subjects w/ AD in Comparison to Healthy Subjects

Vessel Wall Imaging for Diagnosis and Monitoring of Central Nervous System (CNS) Vasculitis

Inpatient Hospice Transitions Checklist

AMO-01 to Treat Adolescents and Adults With Phelan-McDermid Syndrome (PMS) and Co-morbid Epilepsy

Telemedicine in Early Childhood Constraint Therapy in Cerebral Palsy

Temozolomide in Treating Patients With Newly Diagnosed Anaplastic Oligodendroglioma or Mixed Oligoastrocytoma

American Migraine Prevention Study

Lifestyle Enriching Activities for Research in Neuroscience Intervention Trial: LEARNit Study

A Double-blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥ 16 to 75 Years Old) With Partial Onset Seizures

Statin Neuroprotection and Carotid Endarterectomy: Safety, Feasibility and Outcomes

Stroke and CPAP Outcome Study 2

Sensory Stimulation During CIMT

Accelerated rTMS vs. Sham for Stroke Apathy

Determine Range of Tissue Frataxin Concentrations and Other Potential Biomarkers

Safety of Cultured Allogeneic Adult Umbilical-cord or Placental Derived Mesenchymal Stem Cell Intrathecal Injection for SCI